Search results
Results from the WOW.Com Content Network
Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type 1 and type 2 diabetes. [7] It is injected just under the skin . [ 7 ]
South Africa (1971), India (1984), United Nations (1971–1988) Withdrawn because of risk of addiction and overdose [33] [34] Metipranolol: 1990 UK, others Uveitis. [3] Metofoline: 1965 US Unspecific experimental toxicity. [3] Mibefradil: 1998 European Union, Malaysia, US, others Fatal arrhythmia, drug interactions. [2] [3] Minaprine: 1996 ...
Insulin glargine/lixisenatide is approved as a prescription for adults with type 2 diabetes mellitus poorly controlled by lixisenatide or basal insulin alone. [6] According to the American Diabetes Association, combination treatment of a GLP-1 receptor agonist with basal insulin should occur after HbA1C levels remain above target (7% for most type 2 people with diabetes) following use of basal ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Two Indian chemical companies have been indicted for allegedly importing ingredients for the highly addictive opioid fentanyl into the United States and Mexico, the U.S. Department of Justice said ...
From a page move: This is a redirect from a page that has been moved (renamed).This page was kept as a redirect to avoid breaking links, both internal and external, that may have been made to the old page name.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Sanofi was founded in 15 February 1973 [5] as a subsidiary of Elf Aquitaine (a French oil company subsequently acquired by Total), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company formed in 1947 by Sociéte Belge de l'Azote et des Produits Chimiques du Marly; [6] Labaz developed benziodarone in 1957.